Stratos Product Development today announced its partnership with nanoMR to develop instrumentation for its unique Pathogen Capture System (PCS) that can rapidly isolate multiple cell types, including bacteria, directly from blood. nanoMR's PCS will provide substantially faster pathogen identification, enabling the physician to begin appropriate antibiotic therapy sooner and improve patient outcomes while delivering a class-leading user experience for laboratory personnel.
"Stratos' development expertise, combined with nanoMR's chemistry and research, creates an ideal team to deliver an optimal solution for the market," Jim Macemon, VP of Product Development, nanoMR, said. "We have been impressed with Stratos' depth of engineering expertise, and their extensive portfolio in diagnostic instrument and medical device development has been invaluable to our effort."
With proven benchtop results and research in place, nanoMR came to Stratos with the challenge to develop a cost-effective cassette and processing regimen with an input of up to a 10 milliliter blood sample and output of 50 microliters containing purified DNA. Not only does this require superior product development experience and skill, but also an understanding of the complexities of the chemical and biological processes involved and the challenges of high-volume design, manufacturing and production of fluid-filled cartridges.
In addition to developing the instrument, Stratos is performing product requirements definition, hardware and software design with ISO 13485 design controls, and manufacturing strategy and verification activities with output supporting CE certification for clinical trials in Europe.
Stratos will showcase its partnership with nanoMR at the AACC Clinical Lab Expo at the Los Angeles Convention Center, July 17-19, 2012 in booth #322.